Download gynecology oncology - Brigham and Women`s Hospital

GYNECOLOGIC ONCOLOGY
Ross S. Berkowitz, MD, Director
DIVISION MEMBERS
Sarah Feldman, MD
Colleen Feltmate, MD
Donald P. Goldstein, MD
Neil Horowitz, MD
Robert C. Knapp, MD (Emeritus)
Michael G. Muto, MD
Alex Shu-Wing Ng, PhD
Fellows
Sutapa Ghosh, MD
Nicole Nevadunsky, MD
Noah Rodriguez, MD
MISSION
The mission of the Gynecologic Oncology Division is to excel in patient care and teaching and to
advance the understanding and treatment of gynecologic neoplasia.
We provide comprehensive, multidisciplinary evaluation, treatment and follow-up of patients
with suspected or proven pre-invasive or invasive gynecologic malignancies; including ovarian,
endometrial, cervical, vulvar, vaginal and trophoblastic cancers.
ACCOMPLISHMENTS IN AY 2008-2009
The Division had several important accomplishments during the past academic year:
 Dr. Sarah Feldman computerized all clinical data for the Pap Smear Evaluation Center and
this data base will be an invaluable resource to advance the understanding and care of Pap
smear abnormalities.
 Drs. Colleen Feltmate and Michael Muto completed a study on the role of robotic surgery
in endometrial cancer which was presented at the International Congress on Gynecologic
Robotic Surgery. This study demonstrated that robotic surgery could significantly reduce
operative morbidity in obese patients and the presentation won the award for the best
scientific presentation at the meeting.
 Dr. Neil Horowitz is leading an innovative study of the use of a biologic agent in the therapy
of recurrent or metastatic vulvar cancer and early results are very encouraging.
 Drs. Donald Goldstein and Ross Berkowitz were requested to write review articles on the
current management of gestational trophoblastic disease by the New England Journal of
Medicine and Gynecologic Oncology. Dr. Goldstein was also invited to be the keynote
speaker at the XV World Congress of Gestational Trophoblastic Diseases in Cochin, India in
2009.
 We continue to expand our clinical relationships with affiliated hospitals and collaboration in
research and education across the Dana Farber/Harvard Cancer Center Gynecologic Cancer
Program.
GOALS FOR AY 2009-2010
 Develop new clinical relationships with affiliated hospitals
 Strengthen research efforts in ovarian cancer, cervical neoplasia, endometrial cancer and
gestational trophoblastic disease.
 Strengthen collaboration in research and education across Dana Farber/Harvard Cancer
Center and actively participate in Specialized Program of Research Excellence (SPORE) in
ovarian cancer.
 Advance role of minimally invasive surgery in management of gynecologic malignancies.
 Expand educational outreach to community physicians.